Position in TPST
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$29,283
-$483,276 QoQ
Shares Held
17,856
-90.0% QoQ
Ownership
0.121%
of shares outstanding
% of Portfolio
0.58%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2025
3 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in TPST Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026SABBY MANAGEMENT, LLC holds $972,254 across 8 Biotechnology names. TPST ranks #7 (3.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BCTX |
BriaCell Therapeutics Corp.
|
73,915 | $309,703 | |
| 2 | MBRX |
Moleculin Biotech, Inc.
|
75,021 | $171,798 | |
| 3 | BDRX |
Biodexa Pharmaceuticals Plc
|
257,472 | $159,117 | |
| 4 | CANF |
Can-Fite BioPharma Ltd.
|
42,559 | $131,932 | |
| 5 | REVB |
Revelation Biosciences, Inc.
|
99,432 | $119,318 | |
| 6 | LYRA |
Lyra Therapeutics, Inc.
|
104,059 | $51,103 | |
| 7 | TPST |
Tempest Therapeutics, Inc.
This page
|
17,856 | $29,283 | |
| 8 | CLDI |
Calidi Biotherapeutics, Inc.
|
434,903 | $0 |
All Filings in TPST
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $29,283 | 17,856 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $512,559 | 178,592 | Shares | Defined | 2026-02-17 | |
| 2025-06-30 | $1,880,791 | 276,587 | Shares | Defined | 2025-08-14 | |
| No filing history on record for this holder in this stock. | ||||||